Advisory Alpha LLC Has $925,000 Stock Position in Stryker Co. (NYSE:SYK)

Advisory Alpha LLC lowered its position in shares of Stryker Co. (NYSE:SYK) by 14.3% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,485 shares of the medical technology company’s stock after selling 416 shares during the quarter. Advisory Alpha LLC’s holdings in Stryker were worth $925,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Kohmann Bosshard Financial Services LLC acquired a new position in Stryker in the fourth quarter valued at about $25,000. Capital A Wealth Management LLC acquired a new position in Stryker in the fourth quarter valued at about $26,000. Rakuten Securities Inc. raised its stake in Stryker by 618.2% in the fourth quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company’s stock valued at $28,000 after purchasing an additional 68 shares in the last quarter. Centricity Wealth Management LLC acquired a new position in Stryker in the fourth quarter valued at about $30,000. Finally, BankPlus Trust Department acquired a new position in Stryker in the fourth quarter valued at about $33,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Insider Activity at Stryker

In related news, Director Ronda E. Stryker sold 200,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total value of $75,392,000.00. Following the sale, the director now directly owns 3,417,326 shares in the company, valued at $1,288,195,208.96. This represents a 5.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 5.20% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

SYK has been the subject of a number of analyst reports. Barclays boosted their price target on Stryker from $418.00 to $443.00 and gave the company an “overweight” rating in a research note on Monday, February 10th. Argus set a $450.00 target price on Stryker in a research report on Monday, February 3rd. Sanford C. Bernstein set a $450.00 target price on Stryker in a research report on Monday, May 5th. Wall Street Zen cut Stryker from a “buy” rating to a “hold” rating in a research report on Thursday, March 6th. Finally, Truist Financial lifted their target price on Stryker from $390.00 to $400.00 and gave the company a “hold” rating in a research report on Monday, May 5th. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $427.30.

Stryker Stock Performance

Shares of SYK stock opened at $382.86 on Friday. The business’s 50 day simple moving average is $368.77 and its 200 day simple moving average is $376.14. Stryker Co. has a one year low of $314.93 and a one year high of $406.19. The stock has a market capitalization of $146.13 billion, a PE ratio of 49.34, a PEG ratio of 2.93 and a beta of 0.93. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32.

Stryker (NYSE:SYK) last announced its earnings results on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, beating the consensus estimate of $2.73 by $0.11. Stryker had a return on equity of 23.58% and a net margin of 13.25%. The business had revenue of $5.87 billion for the quarter, compared to analysts’ expectations of $5.68 billion. During the same period in the prior year, the business posted $2.50 earnings per share. The firm’s revenue was up 11.9% on a year-over-year basis. As a group, research analysts forecast that Stryker Co. will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be issued a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 0.88%. The ex-dividend date of this dividend is Monday, June 30th. Stryker’s payout ratio is presently 45.41%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.